Unimed Medical Center is launching a new clinical trial for patients with moderate to severe atopic dermatitis, allowing access to advanced biologic therapy under strict medical supervision.
If you suffer from chronic skin problems that don't respond well enough to standard treatments, this may be an option for you.
Atopic dermatitis is a chronic inflammatory skin disease characterized by:
In moderate and severe forms, the disease can significantly affect quality of life, sleep and daily comfort.
Modern biological therapies target specific mechanisms in the immune system that underlie inflammation in atopic dermatitis.
They differ from standard treatments, such as:
A clinical trial is a highly regulated process that evaluates the effectiveness and safety of new therapies.
Participation includes:
All procedures are conducted according to international Good Clinical Practice (GCP) standards.
The study is aimed at patients:
Each patient undergoes an individual assessment by a specialist.
Participation in a clinical study can provide:
If you have atopic dermatitis and are interested in participating in a clinical trial, you can contact us for more information.
Contact:
Dr. Marina Sankeva, Principal Investigator
Phone: +359 88 9436613
Our team will guide you and answer all your questions.
A new clinical trial for atopic dermatitis with biologic therapy is an option for patients seeking a more contemporary approach to treating the disease. With proper assessment and medical follow-up, participation can be an important step toward better symptom control and a higher quality of life.
Contact us for a consultation, research information or partnership. We will assist you with care and professionalism.
